Status:
ACTIVE_NOT_RECRUITING
Anterolateral Versus Direct Lateral Approach in Hemiarthroplasty for Hip Fracture
Lead Sponsor:
Sykehuset Innlandet HF
Conditions:
Hip Fractures
Eligibility:
All Genders
Phase:
NA
Brief Summary
Patients with dislocated hip fractures are randomised to cemented hemiarthroplasty with an anterolateral approach or a direct lateral approach.
Detailed Description
Dislocated intracapsular hip fractures are usually treated with cemented hemiarthroplasty. In Norway, a direct lateral approach is most often used, as recommended in national guidelines. In total hip ...
Eligibility Criteria
Inclusion
- dislocated hip fracture.
- planned cemented hemiarthroplasty.
- able to walk, with or without walking aids, prior to the injury.
Exclusion
- young and healthy patients with displaced hip fractures who are recommended total hip arthroplasty or open reduction / internal fixation of the fracture.
- patients with severe comorbidity and high risk of cement-related complications who are recommended uncemented hemiarthroplasty (some, but not all, patients with ASA (American Society of Anesthesiologists) grade 4).
- not able to give informed consent.
Key Trial Info
Start Date :
June 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04870151
Start Date
June 1 2021
End Date
December 31 2026
Last Update
May 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Innlandet Hospital Trust
Gjøvik, Innlandet, Norway, 2819